Wolfgang Miesbach: Can Gene Therapy Redefine Aging and Healthy Longevity?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yan Zhang et al., published in Ageing Research Reviews:
“Gene Therapy Meets Aging Biology.
A recent review explores how genetic tools could one day modify core aging mechanisms, not just individual diseases.
- AAV‑based delivery to add ‘protective’ genes (e.g. factors supporting mitochondria, telomeres, or stress resistance) to vulnerable organs.
- Gene silencing/editing (CRISPR, base editors, RNA tools) to switch off toxic proteins and disease‑driving variants seen in neurodegeneration and cardiomyopathy.
- Partial reprogramming signals that nudge cells toward a more ‘youthful’ gene‑expression state while preserving their identity.
What excites me most is the paradigm shift: these approaches aim at upstream biology that feeds many conditions at once.
If we can balance efficacy, safety, and ethics, this could redefine prevention and ‘healthy longevity‘ in clinical practice.”
Title: Gene therapy for aging: Current evidence and future directions
Authors: Yan Zhang, Lianli Gan, Shixuan Wang, Jinjin Zhang
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Sep 14, 2026, 09:44Mohammad Salar Amoli: Thrombin The Master Regulator of Coagulation
-
Sep 14, 2026, 09:23Claire Harrison: HemaSphere Introduces New Patient Editor Role
-
Sep 14, 2026, 09:13Eirini Zorba: Plasmapheresis in Focus Understanding Its Role in Patient Care
-
Sep 14, 2026, 08:55Abdulrahman Al-Mashdali։ Immune Checkpoint Inhibitor Associated HLH
-
Sep 14, 2026, 07:54Islam Sadek: SOHO2026 Highlights Advances in Hematologic Malignancies
-
Sep 14, 2026, 07:45Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol – Will AI Replace Clinicians?
-
Sep 14, 2026, 07:19Ruhi Mehra: The Evolving Science of Stem Cell Enumeration